Attached files

file filename
8-K - 8-K - DigitalBridge Group, Inc.form8-kearningsrelease2018.htm
EX-99.1 - EXHIBIT 99.1 - DigitalBridge Group, Inc.exhibit9912018q2pressrelea.htm
clnyfinancialrptcover1.jpg


Cautionary Statement Regarding Forward-Looking Statements
 

This presentation may contain forward-looking statements within the meaning of the federal securities laws. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by the use of forward-looking terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” or “potential” or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. You can also identify forward-looking statements by discussions of strategy, plans or intentions.

Forward-looking statements involve known and unknown risks, uncertainties, assumptions and contingencies, many of which are beyond the Company’s control, and may cause the Company’s actual results to differ significantly from those expressed in any forward-looking statement.

Factors that might cause such a difference include, without limitation, our failure to achieve anticipated synergies in and benefits of the completed merger among NorthStar Asset Management Group Inc., Colony Capital, Inc. and NorthStar Realty Finance Corp., the impact of changes to organizational structure and employee composition, Colony Capital’s liquidity, including its ability to complete sales of non-core investments, whether Colony Capital will be able to maintain its qualification as a real estate investment trust, or REIT, for U.S. federal income tax purposes, the timing of and ability to deploy available capital, Colony Capital's ability to grow its third-party investment management business, the timing and pace of growth in the Company's industrial platform,the performance of the Company's investment in Colony Credit Real Estate, Inc., whether the Company will realize any anticipated benefits from the Digital Bridge partnership, the timing of and ability to complete additional repurchases of Colony Capital’s stock, Colony Capital’s ability to maintain inclusion and relative performance on the RMZ, Colony Capital’s leverage, including the ability to reduce debt and the timing and amount of borrowings under its credit facility, increased interest rates and operating costs, the impact of amendments to the Company's agreements with its managed companies, adverse economic or real estate developments in Colony Capital’s markets, Colony Capital’s failure to successfully operate or lease acquired properties, decreased rental rates, increased vacancy rates or failure to renew or replace expiring leases, increased costs of capital expenditures, defaults on or non-renewal of leases by tenants, the impact of economic conditions on the borrowers of Colony Capital’s commercial real estate debt investments and the commercial mortgage loans underlying its commercial mortgage backed securities, adverse general and local economic conditions, an unfavorable capital market environment, decreased leasing activity or lease renewals, and other risks and uncertainties detailed in our filings with the U.S. Securities and Exchange Commission (“SEC”).

Statements regarding the following subjects, among others, may constitute forward-looking statements: the market, economic and environmental conditions in the Company’s real estate investment sectors; the Company’s business and investment strategy; the Company’s ability to dispose of its real estate investments; the performance of the real estate in which the Company owns an interest; market trends in the Company’s industry, interest rates, real estate values, the debt securities markets or the general economy; actions, initiatives and policies of the U.S. government and changes to U.S. government policies and the execution and impact of these actions, initiatives and policies; the state of the U.S. and global economy generally or in specific geographic regions; the Company’s ability to obtain and maintain financing arrangements, including securitizations; the amount and value of commercial mortgage loans requiring refinancing in future periods; the availability of attractive investment opportunities; the general volatility of the securities markets in which the Company participates; changes in the value of the Company’s assets; the impact of and changes in governmental regulations, tax law and rates, accounting guidance and similar matters; the Company’s ability to maintain its qualification as a real estate investment trust, or REIT, for U.S. federal income tax purposes; and the Company’s ability to maintain its exemption from registration as an investment company under the Investment Company Act of 1940, as amended.

All forward-looking statements reflect Colony Capital’s good faith beliefs, assumptions and expectations, but they are not guarantees of future performance. Additional information about these and other factors can be found in Colony Capital’s reports filed from time to time with the SEC. Colony Capital cautions investors not to unduly rely on any forward-looking statements. The forward-looking statements speak only as of the date of this presentation. Colony Capital is under no duty to update any of these forward-looking statements after the date of this presentation, nor to conform prior statements to actual results or revised expectations, and Colony Capital does not intend to do so.

This presentation may contain statistics and other data that has been obtained or compiled from information made available by third-party service providers. Colony Capital has not independently verified such statistics or data.

This presentation is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Colony Capital. This information is not intended to be indicative of future results. Actual performance of Colony Capital may vary materially.

The appendices herein contain important information that is material to an understanding of this presentation and you should read this presentation only with and in context of the appendices.

Colony Capital | Supplemental Financial Report
 
 


Important Note Regarding Non-GAAP Financial Measures
 

This supplemental package includes certain “non-GAAP” supplemental measures that are not defined by generally accepted accounting principles, or GAAP, including; funds from operations, or FFO; core funds from operations, or Core FFO; net operating income (“NOI”); earnings before interest, tax, depreciation and amortization (“EBITDA”); and pro rata financial information.

FFO: The Company calculates funds from operations ("FFO") in accordance with standards established by the Board of Governors of the National Association of Real Estate Investment Trusts, which defines FFO as net income or loss calculated in accordance with GAAP, excluding extraordinary items, as defined by GAAP, gains and losses from sales of depreciable real estate and impairment write-downs associated with depreciable real estate, plus real estate-related depreciation and amortization, and after similar adjustments for unconsolidated partnerships and joint ventures. Included in FFO are gains and losses from sales of assets which are not depreciable real estate such as loans receivable, investments in unconsolidated joint ventures as well as investments in debt and other equity securities, as applicable.

Core FFO: The Company computes core funds from operations ("Core FFO") by adjusting FFO for the following items, including the Company’s share of these items recognized by its unconsolidated partnerships and joint ventures: (i) gains and losses from sales of depreciable real estate within the Other Equity and Debt segment, net of depreciation, amortization and impairment previously adjusted for FFO; (ii) gains and losses from sales of businesses within the Investment Management segment and impairment write-downs associated with the Investment Management segment; (iii) equity-based compensation expense; (iv) effects of straight-line rent revenue and expense; (v) amortization of acquired above- and below-market lease values; (vi) amortization of deferred financing costs and debt premiums and discounts; (vii) unrealized fair value gains or losses and foreign currency remeasurements; (viii) acquisition-related expenses, merger and integration costs; (ix) amortization and impairment of finite-lived intangibles related to investment management contracts and customer relationships; (x) gain on remeasurement of consolidated investment entities and the effect of amortization thereof; (xi) non-real estate depreciation and amortization; (xii) change in fair value of contingent consideration; and (xiii) tax effect on certain of the foregoing adjustments. Beginning with the first quarter of 2018, the Company’s Core FFO from its interest in Colony Credit Real Estate, Inc. (NYSE: CLNC) and NorthStar Realty Europe Corp. (NYSE: NRE) represented its percentage interest multiplied by CLNC’s Core Earnings and NRE’s Cash Available for Distribution (“CAD”), respectively. Refer to CLNC’s and NRE's respective filings with the SEC for the definition and calculation of Core Earnings and CAD.

FFO and Core FFO should not be considered alternatives to GAAP net income as indications of operating performance, or to cash flows from operating activities as measures of liquidity, nor as indications of the availability of funds for our cash needs, including funds available to make distributions. FFO and Core FFO should not be used as supplements to or substitutes for cash flow from operating activities computed in accordance with GAAP. The Company’s calculations of FFO and Core FFO may differ from methodologies utilized by other REITs for similar performance measurements, and, accordingly, may not be comparable to those of other REITs.

The Company uses FFO and Core FFO as supplemental performance measures because, in excluding real estate depreciation and amortization and gains and losses from property dispositions, it provides a performance measure that captures trends in occupancy rates, rental rates, and operating costs. The Company also believes that, as widely recognized measures of the performance of REITs, FFO and Core FFO will be used by investors as a basis to compare its operating performance with that of other REITs. However, because FFO and Core FFO exclude depreciation and amortization and capture neither the changes in the value of the Company’s properties that resulted from use or market conditions nor the level of capital expenditures and leasing commissions necessary to maintain the operating performance of its properties, all of which have real economic effect and could materially impact the Company’s results from operations, the utility of FFO and Core FFO as measures of the Company’s performance is limited. FFO and Core FFO should be considered only as supplements to net income as a measure of the Company’s performance.








Colony Capital | Supplemental Financial Report
 
 


Important Note Regarding Non-GAAP Financial Measures
 

NOI and EBITDA: The Company believes that NOI and EBITDA are useful measures of operating performance of its respective real estate portfolios as they are more closely linked to the direct results of operations at the property level. NOI also reflects actual rents received during the period after adjusting for the effects of straight-line rents and amortization of above- and below- market leases; therefore, a comparison of NOI across periods better reflects the trend in occupancy rates and rental rates of the Company’s properties.

NOI and EBITDA exclude historical cost depreciation and amortization, which are based on different useful life estimates depending on the age of the properties, as well as adjust for the effects of real estate impairment and gains or losses on sales of depreciated properties, which eliminate differences arising from investment and disposition decisions. This allows for comparability of operating performance of the Company’s properties period over period and also against the results of other equity REITs in the same sectors. Additionally, by excluding corporate level expenses or benefits such as interest expense, any gain or loss on early extinguishment of debt and income taxes, which are incurred by the parent entity and are not directly linked to the operating performance of the Company’s properties, NOI and EBITDA provide a measure of operating performance independent of the Company’s capital structure and indebtedness. However, the exclusion of these items as well as others, such as capital expenditures and leasing costs, which are necessary to maintain the operating performance of the Company’s properties, and transaction costs and administrative costs, may limit the usefulness of NOI and EBITDA. NOI may fail to capture significant trends in these components of U.S. GAAP net income (loss) which further limits its usefulness.

NOI should not be considered as an alternative to net income (loss), determined in accordance with U.S. GAAP, as an indicator of operating performance. In addition, the Company’s methodology for calculating NOI involves subjective judgment and discretion and may differ from the methodologies used by other comparable companies, including other REITs, when calculating the same or similar supplemental financial measures and may not be comparable with other companies.

Pro-rata: The Company presents pro-rata financial information, which is not, and is not intended to be, a presentation in accordance with GAAP. The Company computes pro-rata financial information by applying its economic interest to each financial statement line item on an investment-by-investment basis. Similarly, noncontrolling interests’ share of assets, liabilities, profits and losses was computed by applying noncontrolling interests’ economic interest to each financial statement line item. The Company provides pro-rata financial information because it may assist investors and analysts in estimating the Company’s economic interest in its investments. However, pro-rata financial information as an analytical tool has limitations. Other equity REITs may not calculate their pro-rata information in the same methodology, and accordingly, the Company’s pro-rata information may not be comparable to such other REITs' pro-rata information. As such, the pro-rata financial information should not be considered in isolation or as a substitute for our financial statements as reported under GAAP, but may be used as a supplement to financial information as reported under GAAP.

Tenant/operator provided information: The information related to the Company’s tenants/operators that is provided in this presentation has been provided by, or derived from information provided by, such tenants/operators. The Company has not independently verified this information and has no reason to believe that such information is inaccurate in any material respect. The Company is providing this data for informational purposes only.

Colony Capital | Supplemental Financial Report
 
 


Note Regarding CLNY Reportable Segments / Consolidated and OP Share of Consolidated Amounts

 

Colony Capital holds investment interests in six reportable segments: Healthcare Real Estate; Industrial Real Estate; Hospitality Real Estate; CLNC; Other Equity and Debt; and Investment Management.

Healthcare Real Estate
As of June 30, 2018, the consolidated healthcare portfolio consisted of 413 properties: 192 senior housing properties, 108 medical office properties, 99 skilled nursing facilities and 14 hospitals. The Company’s equity interest in the consolidated Healthcare Real Estate segment was approximately 71% as of June 30, 2018. The healthcare portfolio earns rental and escalation income from leasing space to various healthcare tenants and operators. The leases are for fixed terms of varying length and generally provide for rent and expense reimbursements to be paid in monthly installments. The healthcare portfolio also generates operating income from healthcare properties operated through management agreements with independent third-party operators, predominantly through structures permitted by the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”).

Industrial Real Estate
As of June 30, 2018, the consolidated industrial portfolio consisted of 392 primarily light industrial buildings totaling 47.5 million rentable square feet across 20 major U.S. markets and was 93% leased. During the second quarter 2018, the Company raised $175 million of new third-party capital. As a result, the Company’s equity interest in the consolidated Industrial Real Estate segment decreased to approximately 37% as of June 30, 2018 from 40% as of March 31, 2018. Total third-party capital commitments were approximately $1.4 billion compared to cumulative balance sheet contributions of $749 million as of June 30, 2018. The Company continues to own a 100% interest in the related operating platform. The Industrial Real Estate segment is comprised of and primarily invests in light industrial properties in infill locations in major U.S. metropolitan markets generally targeting multi-tenanted warehouses less than 250,000 square feet.

Hospitality Real Estate
As of June 30, 2018, the consolidated hospitality portfolio consisted of 167 properties: 97 select service properties, 66 extended stay properties and 4 full service properties. The Company’s equity interest in the consolidated Hospitality Real Estate segment was approximately 94% as of June 30, 2018. The hospitality portfolio consists primarily of premium branded select service hotels and extended stay hotels located mostly in major metropolitan markets, of which a majority are affiliated with top hotel brands. The select service hospitality portfolio, referred to as the THL Hotel Portfolio, which the Company acquired through consensual transfer during the third quarter 2017, is not included in the Hospitality Real Estate segment and is included in the Other Equity and Debt segment.

Colony Credit Real Estate, Inc. (“CLNC”)
On February 1, 2018, Colony Credit Real Estate, Inc., a leading commercial real estate credit REIT, announced the completion of the combination of a select portfolio of the Company’s assets and liabilities from the Other Equity and Debt segment with NorthStar Real Estate Income Trust, Inc. (“NorthStar I”) and NorthStar Real Estate Income II, Inc. (“NorthStar II”) in an all-stock transaction. In connection with the closing, CLNC completed the listing of its Class A common stock on the New York Stock Exchange under the ticker symbol “CLNC.” The combination created a permanent capital vehicle, externally managed by the Company, with approximately $4.9 billion in assets, excluding securitization trust liabilities, and $3.1 billion in equity value as of June 30, 2018. The Company owns 48.0 million shares, or 37%, of CLNC and earns an annual base management fee of 1.5% on stockholders’ equity and an incentive fee of 20% of CLNC’s Core Earnings over a 7% hurdle rate.

Other Equity and Debt
The Company owns a diversified group of strategic and non-strategic real estate and real estate-related debt and equity investments. Strategic investments include our 11% interest in NorthStar Realty Europe Corp. (NYSE: NRE) and other investments for which the Company acts as a general partner or manager (“GP Co-Investments”) and receives various forms of investment management economics on the related third-party capital. Non-strategic investments are composed of those investments the Company does not intend to own for the long term including net leased assets; real estate loans; other real estate equity including the THL Hotel Portfolio and the Company’s interest in Albertsons; limited partnership interests in third-party sponsored real estate private equity funds; and multiple classes of commercial real estate (“CRE”) securities.

Investment Management
The Company’s Investment Management segment includes the business and operations of managing capital on behalf of third-party investors through closed and open-end private funds, non-traded and traded real estate investment trusts and registered investment companies.

Throughout this presentation, consolidated figures represent the interest of both the Company (and its subsidiary Colony Capital Operating Company or the “CLNY OP”) and noncontrolling interests. Figures labeled as CLNY OP share represent the Company’s pro-rata share.

Colony Capital | Supplemental Financial Report
 
 


Table of Contents
 

 
 
 
Page
I.
Overview
 
 
a.
Summary Metrics
6
 
b.
Summary of Segments
7-8
II.
Financial Results
 
 
a.
Consolidated Balance Sheet
9
 
b.
Noncontrolling Interests’ Share Balance Sheet
10
 
c.
Consolidated Segment Operating Results
11
 
d.
Noncontrolling Interests’ Share Segment Operating Results
12
 
e.
Segment Reconciliation of Net Income to FFO & Core FFO
13
III.
Capitalization
 
 
a.
Overview
14
 
b.
Investment-Level Debt Overview
15
 
c.
Revolving Credit Facility Overview
16
 
d.
Corporate Securities Overview
17
 
e.
Debt Maturity and Amortization Schedules
18
IV.
Healthcare Real Estate
 
 
a.
Summary Metrics and Operating Results
19
 
b.
Portfolio Overview
20-21
V.
Industrial Real Estate
 
 
a.
Summary Metrics and Operating Results
22
 
b.
Portfolio Overview
23
 
 
 
 
 
 
 
 
Page
VI.
Hospitality Real Estate
 
 
a.
Summary Metrics and Operating Results
24
 
b.
Portfolio Overview
25
VII.
CLNC
 
 
a.
Overview
26
VIII.
Other Equity and Debt
 
 
a.
Strategic Investments
27
 
b.
Net Lease and Other Real Estate Equity
28
 
c.
Real Estate Debt
29-31
 
d.
Real Estate PE Fund Interests
32
 
e.
CRE Securities
33
IX.
Investment Management
 
 
a.
Summary Metrics
34
 
b.
Assets Under Management
35
X.
Appendices
 
 
a.
Definitions
37-38
 
b.
Reconciliation of Net Income (Loss) to NOI/EBITDA
39-40
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


Colony Capital | Supplemental Financial Report
 
5

 




Ia. Overview - Summary Metrics
 

($ and shares in thousands, except per share data and as noted; as of or for the three months ended June 30, 2018, unless otherwise noted) (Unaudited)
Financial Data
 
Net income (loss) attributable to common stockholders
$
(92,806
)
Net income (loss) attributable to common stockholders per basic share
(0.19
)
Core FFO
93,487

Core FFO per basic share
0.18

Q3 2018 dividend per share
0.11

Annualized Q3 2018 dividend per share
0.44

 
 
Balance Sheet, Capitalization and Trading Statistics
 
Total consolidated assets
$
22,819,717

 CLNY OP share of consolidated assets
16,441,662

Total consolidated debt(1)
10,414,000

 CLNY OP share of consolidated debt(1)
7,665,995

Shares and OP units outstanding as of June 30, 2018
520,893

Shares and OP units outstanding as of August 6, 2018(2)
520,893

Share price as of August 6, 2018
6.15

Market value of common equity & OP units as of August 6, 2018
3,203,492

Liquidation preference of perpetual preferred equity(3)
1,436,605

Insider ownership of shares and OP units
6.5
%
Total Assets Under Management ("AUM")
$ 43.0 billion

Fee Earning Equity Under Management ("FEEUM")
$ 17.1 billion









Notes:
In evaluating the information presented throughout this presentation see the appendices to this presentation for definitions and reconciliations of non-GAAP financial measures to GAAP measures.
(1)
Represents principal balance and excludes debt issuance costs, discounts and premiums. See additional footnotes on page 14.
(2) Does not include approximately 2.0 million shares and OP units expected to be issued to senior management as a result of achieving one of the contingent consideration targets for the 2015 Colony Capital, LLC internalization transaction.
(3) Excludes $200 million redeemed in the third quarter 2018.

Colony Capital | Supplemental Financial Report
 
6

 




Ib. Overview - Summary of Segments
 


($ in thousands; as of or for the three months ended June 30, 2018, unless otherwise noted)
Consolidated amount
 
CLNY OP share of
consolidated amount
Healthcare Real Estate
 
 
 
Q2 2018 net operating income(1)(2)
$
73,856

 
$
52,363

Annualized net operating income(3)
309,824

 
219,662

Investment-level non-recourse financing(4)
3,257,637

 
2,321,387

 
 
 
 
Industrial Real Estate
 
 
 
Q2 2018 net operating income(2)
49,078

 
18,257

Annualized net operating income
196,312

 
73,028

Investment-level non-recourse financing(4)
1,073,830

 
399,788

 
 
 
 
Hospitality Real Estate
 
 
 
Q2 2018 EBITDA(2)
85,978

 
81,077

TTM EBITDA(5)
284,144

 
267,946

Investment-level non-recourse financing(4)
2,610,222

 
2,439,349












Notes:
(1)
NOI includes $1.4 million consolidated or $1.0 million CLNY OP share of interest earned related to $77 million consolidated or $54 million CLNY OP share carrying value of healthcare real estate development loans. This interest income is in the Interest Income line item on the Company’s Statement of Operations for the three months ended June 30, 2018.
(2)
For a reconciliation of net income/(loss) attributable to common stockholders to NOI/EBITDA, please refer to the appendix to this presentation.
(3)
Excludes $3.6 million consolidated or $2.5 million CLNY OP share of second quarter 2018 non-recurring bad debt expense.
(4)
Represents unpaid principal balance.
(5)
TTM = trailing twelve month.

Colony Capital | Supplemental Financial Report
 
7

 




Ib. Overview - Summary of Segments (cont’d)
 

($ in thousands except as noted; as of or for the three months ended June 30, 2018, unless otherwise noted)
Consolidated amount
 
CLNY OP share of consolidated amount
CLNC
 
 
 
Net carrying value of 37% interest
$
1,146,355

 
$
1,146,355

Other Equity and Debt(1)
 
 
 
1) Strategic Investments
 
 
 
a) GP co-investments - net carrying value
1,144,034

 
421,742

b) Net carrying value of 11% interest in NRE
75,044

 
75,044

2) Net lease real estate equity
 
 
 
a) Q2 2018 net operating income
7,929

 
7,797

b) Investment-level non-recourse financing(2)
335,375

 
334,739

3) Other real estate equity
 
 
 
a) Undepreciated carrying value of real estate assets(3)
2,453,176

 
1,271,563

b) Investment-level non-recourse financing(2)
1,509,183

 
790,907

c) Carrying value - unconsolidated / equity method investments (including Albertsons)
554,714

 
477,016

4) Real estate debt
 
 
 
a) Carrying value - consolidated(4)
614,491

 
407,556

b) Investment-level non-recourse financing(2)
36,747

 
23,779

c) Carrying value - equity method investments
28,405

 
20,895

d) Carrying value - real estate assets (REO within debt portfolio) and other(3)
25,721

 
14,689

5) Real estate PE fund investments
 
 
 
a) Carrying value
 
 
142,744

6) CRE securities
 
 
 
a) Net carrying value
 
 
78,206

Investment Management
 
 
 
Third-party AUM ($ in millions)
 
 
28,144

FEEUM ($ in millions)
 
 
17,080

Q2 2018 fee revenue and REIM platform earnings of investments in unconsolidated ventures
 
 
39,116

Net Assets
 
 
 
Cash and cash equivalents, restricted cash and other assets(5)
1,194,887

 
902,574

Accrued and other liabilities and dividends payable(6)
912,833

 
745,867

Net assets
282,054

 
156,707

Notes:
(1)
Includes assets classified as held for sale on the Company’s financial statements.
(2)
Represents unpaid principal balance.
(3)
Includes all components related to real estate assets, including tangible real estate and lease-related intangibles, and excludes accumulated depreciation.
(4)
Excludes $77 million consolidated or $54 million CLNY OP share carrying value of healthcare real estate development loans.
(5)
Other assets exclude $10 million consolidated or $8 million CLNY OP share of deferred financing costs and restricted cash excludes $150 million consolidated or $83 million CLNY OP share of restricted cash which is included in the undepreciated carrying value of the hotel portfolio in Other Real Estate Equity shown on page 28.
(6)
Accrued and other liabilities exclude $63 million consolidated and CLNY OP share of deferred tax liabilities and other liabilities which are not due in cash and includes $200 million preferred stock redemption payable.

Colony Capital | Supplemental Financial Report
 
8

 




IIa. Financial Results - Consolidated Balance Sheet
 


($ in thousands, except per share data) (Unaudited)
 
As of June 30, 2018
Assets
 
 
Cash and cash equivalents
 
$
480,230

Restricted cash
 
398,981

Real estate, net
 
14,254,108

Loans receivable, net
 
1,791,889

Investments in unconsolidated ventures
 
2,491,342

Securities, at fair value
 
144,421

Goodwill
 
1,534,561

Deferred leasing costs and intangible assets, net
 
610,853

Assets held for sale
 
637,802

Other assets
 
431,222

Due from affiliates
 
44,308

Total assets
 
$
22,819,717

Liabilities
 
 
Debt, net
 
$
9,994,115

Accrued and other liabilities
 
679,658

Intangible liabilities, net
 
173,702

Liabilities related to assets held for sale
 
256,477

Due to affiliates
 
9,383

Dividends and distributions payable
 
86,656

Preferred stock redemptions payable
 
200,000

Total liabilities
 
11,399,991

Commitments and contingencies
 
 
Redeemable noncontrolling interests
 
33,523

Equity
 
 
Stockholders’ equity:
 
 
Preferred stock, $0.01 par value per share; $1,436,605 liquidation preference; 250,000 shares authorized; 57,464 shares issued and outstanding
 
1,407,495

Common stock, $0.01 par value per share
 
 
Class A, 949,000 shares authorized; 489,764 shares issued and outstanding
 
4,898

Class B, 1,000 shares authorized; 708 shares issued and outstanding
 
7

Additional paid-in capital
 
7,616,918

Distributions in excess of earnings
 
(1,443,717
)
Accumulated other comprehensive income (loss)
 
23,930

Total stockholders’ equity
 
7,609,531

Noncontrolling interests in investment entities
 
3,393,981

Noncontrolling interests in Operating Company
 
382,691

Total equity
 
11,386,203

Total liabilities, redeemable noncontrolling interests and equity
 
$
22,819,717


Colony Capital | Supplemental Financial Report
 
9

 




IIb. Financial Results - Noncontrolling Interests’ Share Balance Sheet
 

($ in thousands, except per share data) (Unaudited)
 
As of June 30, 2018
Assets
 
 
Cash and cash equivalents
 
$
182,307

Restricted cash
 
126,115

Real estate, net
 
4,677,850

Loans receivable, net
 
740,195

Investments in unconsolidated ventures
 
255,612

Securities, at fair value
 
28,251

Goodwill
 

Deferred leasing costs and intangible assets, net
 
169,591

Assets held for sale
 
144,912

Other assets
 
59,530

Due from affiliates
 
(6,308
)
Total assets
 
$
6,378,055

Liabilities
 
 
Debt, net
 
$
2,708,407

Accrued and other liabilities
 
166,962

Intangible liabilities, net
 
57,318

Liabilities related to assets held for sale
 
17,860

Due to affiliates
 
4

Dividends and distributions payable
 

Preferred stock redemptions payable
 

Total liabilities
 
2,950,551

Commitments and contingencies
 

Redeemable noncontrolling interests
 
33,523

Equity
 
 
Stockholders’ equity:
 
 
Preferred stock, $0.01 par value per share; $1,436,605 liquidation preference; 250,000 shares authorized; 57,464 shares issued and outstanding
 

Common stock, $0.01 par value per share
 
 
Class A, 949,000 shares authorized; 489,764 shares issued and outstanding
 

Class B, 1,000 shares authorized; 708 shares issued and outstanding
 

Additional paid-in capital
 

Distributions in excess of earnings
 

Accumulated other comprehensive income (loss)
 

Total stockholders’ equity
 

Noncontrolling interests in investment entities
 
3,393,981

Noncontrolling interests in Operating Company
 

Total equity
 
3,393,981

Total liabilities, redeemable noncontrolling interests and equity
 
$
6,378,055



Colony Capital | Supplemental Financial Report
 
10

 




IIc. Financial Results - Consolidated Segment Operating Results
 

 
 
Three Months Ended June 30, 2018
($ in thousands) (Unaudited)
 
Healthcare
 
Industrial
 
Hospitality
 
CLNC
 
Other Equity and Debt
 
Investment
Management
 
Amounts not
allocated to
segments
 
Total
Revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Property operating income
 
$
143,839

 
$
71,685

 
$
229,259

 
$

 
$
145,855

 
$

 
$

 
$
590,638

Interest income
 
1,409

 
62

 

 

 
42,586

 

 
126

 
44,183

Fee income
 

 

 

 

 

 
39,924

 

 
39,924

Other income
 
171

 
730

 
114

 

 
2,509

 
9,619

 
1,711

 
14,854

 Total revenues
 
145,419

 
72,477

 
229,373

 

 
190,950

 
49,543

 
1,837

 
689,599

Expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Property operating expense
 
69,983

 
20,483

 
143,321

 

 
86,887

 

 

 
320,674

Interest expense
 
45,179

 
10,856

 
36,494

 

 
46,476

 

 
14,304

 
153,309

Investment, servicing and commission expense
 
3,110

 
60

 
3,546

 

 
11,028

 
5,923

 
2,284

 
25,951

Transaction costs
 

 

 

 

 
2,334

 

 
307

 
2,641

Depreciation and amortization
 
38,229

 
32,482

 
35,925

 

 
23,521

 
6,204

 
1,535

 
137,896

Provision for loan loss
 

 

 

 

 
13,933

 

 

 
13,933

Impairment loss
 
1,982

 
174

 

 

 
7,366

 
60,312

 

 
69,834

Compensation expense
 
1,751

 
2,632

 
1,514

 

 
2,783

 
15,299

 
31,180

 
55,159

Administrative expenses
 
445

 
1,084

 
84

 

 
3,192

 
1,959

 
19,026

 
25,790

 Total expenses
 
160,679

 
67,771

 
220,884

 

 
197,520

 
89,697

 
68,636

 
805,187

Other income (loss)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gain on sale of real estate assets
 

 

 

 

 
42,702

 

 

 
42,702

Other gain (loss), net
 
(4,465
)
 

 
(162
)
 

 
18,216

 
(123
)
 
15,332

 
28,798

Earnings of investments in unconsolidated ventures
 

 

 

 
5,413

 
7,767

 
(11,305
)
 

 
1,875

Income (loss) before income taxes
 
(19,725
)
 
4,706

 
8,327

 
5,413

 
62,115

 
(51,582
)
 
(51,467
)
 
(42,213
)
Income tax benefit (expense)
 
(355
)
 
(38
)
 
(1,556
)
 

 
(262
)
 
2,882

 
(87
)
 
584

Net income (loss) from continuing operations
 
(20,080
)
 
4,668

 
6,771

 
5,413

 
61,853

 
(48,700
)
 
(51,554
)
 
(41,629
)
Income (loss) from discontinued operations
 

 

 

 

 
(219
)
 

 

 
(219
)
Net income (loss)
 
(20,080
)
 
4,668

 
6,771

 
5,413

 
61,634

 
(48,700
)
 
(51,554
)
 
(41,848
)
Net income (loss) attributable to noncontrolling interests:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Redeemable noncontrolling interests
 

 

 

 

 
1,873

 

 

 
1,873

Investment entities
 
(4,841
)
 
3,807

 
658

 

 
26,504

 
1,292

 

 
27,420

Operating Company
 
(883
)
 
51

 
346

 
309

 
1,924

 
(2,922
)
 
(4,553
)
 
(5,728
)
Net income (loss) attributable to Colony Capital, Inc.
 
(14,356
)
 
810

 
5,767

 
5,104

 
31,333

 
(47,070
)
 
(47,001
)
 
(65,413
)
Preferred stock redemption
 

 

 

 

 

 

 
(3,995
)
 
(3,995
)
Preferred stock dividends
 

 

 

 

 

 

 
31,388

 
31,388

Net income (loss) attributable to common stockholders
 
$
(14,356
)
 
$
810

 
$
5,767

 
$
5,104

 
$
31,333

 
$
(47,070
)
 
$
(74,394
)
 
$
(92,806
)

Colony Capital | Supplemental Financial Report
 
11

 




IId. Financial Results - Noncontrolling Interests’ Share Segment Operating Results

 

 
 
Three Months Ended June 30, 2018
($ in thousands) (Unaudited)
 
Healthcare
 
Industrial
 
Hospitality
 
CLNC
 
Other Equity and Debt
 
Investment
Management
 
Amounts not
allocated to
segments
 
Total
Revenues
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
Property operating income
 
$
40,631

 
$
41,576

 
$
14,121

 
$

 
$
63,420

 
$

 
$

 
$
159,748

Interest income
 
428

 
36

 

 

 
19,280

 

 

 
19,744

Fee income
 

 

 

 

 

 

 

 

Other income
 
52

 

 
9

 

 
1,379

 

 

 
1,440

 Total revenues
 
41,111

 
41,612

 
14,130

 

 
84,079

 

 

 
180,932

Expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Property operating expense
 
18,910

 
11,968

 
8,698

 

 
38,877

 

 

 
78,453

Interest expense
 
12,892

 
6,255

 
2,367

 

 
14,037

 

 

 
35,551

Investment, servicing and commission expense
 
871

 
35

 
137

 

 
3,844

 

 

 
4,887

Transaction costs
 

 

 

 

 
1,557

 

 

 
1,557

Depreciation and amortization
 
11,012

 
18,985

 
2,248

 

 
10,261

 

 

 
42,506

Provision for loan loss
 

 

 

 

 
6,647

 

 

 
6,647

Impairment loss
 
601

 
101

 

 

 
4,877

 

 

 
5,579

Compensation expense
 

 
14

 

 

 
363

 

 

 
377

Administrative expenses
 
109

 
423

 

 

 
1,657

 

 

 
2,189

 Total expenses
 
44,395

 
37,781

 
13,450

 

 
82,120

 

 

 
177,746

Other income (loss)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gain on sale of real estate assets
 

 

 

 

 
19,647

 

 

 
19,647

Other gain (loss), net
 
(1,355
)
 

 
(22
)
 

 
3,313

 

 

 
1,936

Earnings of investments in unconsolidated ventures
 

 

 

 

 
4,245

 
1,292

 

 
5,537

Income (loss) before income taxes
 
(4,639
)
 
3,831

 
658

 

 
29,164

 
1,292

 

 
30,306

Income tax benefit (expense)
 
(109
)
 
(24
)
 

 

 
(688
)
 

 

 
(821
)
Net income (loss) from continuing operations
 
(4,748
)
 
3,807

 
658

 

 
28,476

 
1,292

 

 
29,485

Income (loss) from discontinued operations
 

 

 

 

 
(99
)
 

 

 
(99
)
Non-pro rata allocation of income (loss) to NCI
 
(93
)
 

 

 

 

 

 

 
(93
)
Net income (loss) attributable to noncontrolling interests
 
$
(4,841
)
 
$
3,807

 
$
658

 
$

 
$
28,377

 
$
1,292

 
$

 
$
29,293



Colony Capital | Supplemental Financial Report
 
12

 




IIe. Financial Results - Segment Reconciliation of Net Income to FFO & Core FFO
 

 
 
Three Months Ended June 30, 2018
 
 
OP pro rata share by segment
 
Amounts
attributable to
noncontrolling interests
 
CLNY consolidated as reported
($ in thousands) (Unaudited)
 
Healthcare
 
Industrial
 
Hospitality
 
CLNC
 
Other Equity and Debt
 
Investment
Management
 
Amounts not
allocated to
segments
 
Total OP pro rata share
 
 
Net income (loss) attributable to common stockholders
 
$
(14,356
)
 
$
810

 
$
5,767

 
$
5,104

 
$
31,333

 
$
(47,070
)
 
$
(74,394
)
 
$
(92,806
)
 
$

 
$
(92,806
)
Net income (loss) attributable to noncontrolling common interests in Operating Company
 
(883
)
 
51

 
346

 
309

 
1,924

 
(2,922
)
 
(4,553
)
 
(5,728
)
 

 
(5,728
)
Net income (loss) attributable to common interests in Operating Company and common stockholders
 
(15,239
)
 
861

 
6,113

 
5,413

 
33,257

 
(49,992
)
 
(78,947
)
 
(98,534
)
 

 
(98,534
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Adjustments for FFO:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Real estate depreciation and amortization
 
25,763

 
13,448

 
33,219

 
8,279

 
14,755

 
785

 

 
96,249

 
44,350

 
140,599

Impairment of real estate
 
1,381

 
72

 

 

 
2,489

 

 

 
3,942

 
5,580

 
9,522

Gain from sales of real estate
 

 

 

 

 
(22,243
)
 
(48
)
 

 
(22,291
)
 
(20,459
)
 
(42,750
)
Less: Adjustments attributable to noncontrolling interests in investment entities
 

 

 

 

 

 

 

 

 
(29,471
)
 
(29,471
)
FFO
 
$
11,905

 
$
14,381

 
$
39,332

 
$
13,692

 
$
28,258

 
$
(49,255
)
 
$
(78,947
)
 
$
(20,634
)
 
$

 
$
(20,634
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Additional adjustments for Core FFO:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Gains) and losses from sales of depreciable real estate within the Other Equity and Debt segment, net of depreciation, amortization and impairment previously adjusted for FFO(1)
 

 

 

 

 
15,619

 

 

 
15,619

 
14,368

 
29,987

(Gains) and losses from sales of businesses within the Investment Management segment and impairment write-downs associated with the Investment Management segment
 

 

 

 

 

 
16,437

 

 
16,437

 

 
16,437

Equity-based compensation expense
 
289

 
659

 
250

 
658

 
376

 
1,815

 
5,986

 
10,033

 

 
10,033

Straight-line rent revenue and expense
 
(1,679
)
 
(791
)
 
(4
)
 

 
(683
)
 
(20
)
 
1,028

 
(2,149
)
 
(2,340
)
 
(4,489
)
Change in fair value of contingent consideration
 

 

 

 

 

 

 
8,750

 
8,750

 

 
8,750

Amortization of acquired above- and below-market lease values
 
576

 
(268
)
 
(3
)
 
79

 
18

 

 

 
402

 
31

 
433

Amortization of deferred financing costs and debt premiums and discounts
 
4,026

 
201

 
3,163

 

 
5,913

 
55

 
1,662

 
15,020

 
6,614

 
21,634

Unrealized fair value gains or losses and foreign currency remeasurements
 
3,435

 

 

 
(507
)
 
(2,646
)
 
23

 
(23,996
)
 
(23,691
)
 
(280
)
 
(23,971
)
Acquisition and merger-related transaction costs
 

 

 

 
857

 
827

 

 
308

 
1,992

 
1,557

 
3,549

Merger integration costs(2)
 

 

 

 

 

 

 
8,472

 
8,472

 

 
8,472

Amortization and impairment of investment management intangibles
 

 

 

 

 

 
66,550

 

 
66,550

 

 
66,550

Non-real estate depreciation and amortization
 

 
49

 
458

 

 

 
10

 
1,535

 
2,052

 
48

 
2,100

Gain on remeasurement of consolidated investment entities and the effect of amortization thereof
 

 

 

 

 
104

 

 

 
104

 
1,771

 
1,875

Tax (benefit) expense, net
 

 

 

 

 

 
(1,475
)
 

 
(1,475
)
 

 
(1,475
)
Preferred share redemption gain
 

 

 

 

 

 

 
(3,995
)
 
(3,995
)
 
 
 
(3,995
)
Less: Adjustments attributable to noncontrolling interests in investment entities
 

 

 

 

 

 

 

 

 
(21,769
)
 
(21,769
)
Core FFO
 
$
18,552

 
$
14,231

 
$
43,196

 
$
14,779

 
$
47,786

 
$
34,140

 
$
(79,197
)
 
$
93,487

 
$

 
$
93,487

Notes:
(1)
Net of $2.5 million CLNY OP share of depreciation, amortization and impairment charges previously adjusted to calculate FFO and Core Earnings, a non-GAAP measure used by Colony prior to its internalization of the manager.
(2)
Merger integration costs represent costs and charges incurred during the integration of Colony, NSAM and NRF. These integration costs are not reflective of the Company’s core operating performance and the Company does not expect to incur these costs subsequent to the completion of the merger integration. The majority of integration costs consist of severance, employee costs of those separated or scheduled for separation, system integration and lease terminations.

Colony Capital | Supplemental Financial Report
 
13

 




IIIa. Capitalization - Overview
 

($ in thousands; except per share data; as of June 30, 2018, unless otherwise noted)
 
 
Consolidated amount
 
CLNY OP share of
consolidated amount
 
 
 
 
 
 
Debt (UPB)
 
 
 
 
 
$1,000,000 Revolving credit facility
 
 
$

 
$

Convertible/exchangeable senior notes
 
 
616,105

 
616,105

Corporate aircraft promissory note
 
 
38,213

 
38,213

Trust Preferred Securities ("TruPS")
 
 
280,117

 
280,117

Investment-level debt:
 
 
 
 
 
Healthcare
 
 
3,257,637

 
2,321,387

Industrial
 
 
1,073,830

 
399,788

Hospitality(1)
 
 
2,610,222

 
2,439,349

Other Equity and Debt
 
 
2,537,876

 
1,571,036

Total investment-level debt(2)
 
 
9,479,565

 
6,731,560

Total debt
 
 
$
10,414,000

 
$
7,665,995

 
 
 
 
 
 
Perpetual preferred equity, redemption value
 
 
 
 
 
Total perpetual preferred equity(3)
 
 
 
 
$
1,436,605

 
 
 
 
 
 
Common equity as of August 6, 2018
Price per share
 
Shares / Units
 
 
Class A and B common stock
$
6.15

 
490,466

 
$
3,016,366

OP units
6.15

 
30,427

 
187,126

Total market value of common equity
 
 
 
 
$
3,203,492

 
 
 
 
 
 
Total market capitalization
 
 
 
 
$
12,306,092











Notes:
(1) During the third quarter 2018, refinanced approximately $500 million of consolidated and CLNY OP share of debt in the Hospitality Real Estate segment, extending the fully extended maturity date from 2019 to 2025.
(2) Includes $196 million consolidated and CLNY OP share principal balance of debt related to assets held for sale.
(3) Excludes $200 million redeemed in the third quarter 2018.


Colony Capital | Supplemental Financial Report
 
14

 




IIIb. Capitalization - Investment-Level Debt Overview
 

($ in thousands; as of or for the three months ended June 30, 2018, unless otherwise noted)
Non-recourse investment-level debt overview
 
 
 
 
Consolidated
 
CLNY OP share of consolidated amount
 
 
Fixed / Floating
 
Unpaid principal balance
 
Unpaid principal balance
 
Wtd. avg. years remaining to maturity
 
Wtd. avg. interest rate(1)
Healthcare
 
Fixed
 
$
2,168,914

 
$
1,512,745

 
2.5

 
4.7
%
Healthcare
 
Floating
 
1,088,723

 
808,642

 
2.8

 
6.3
%
Industrial
 
Fixed
 
1,073,830

 
399,788

 
11.1

 
3.8
%
Hospitality
 
Fixed
 
10,790

 
10,520

 
2.6

 
12.9
%
Hospitality
 
Floating
 
2,599,432

 
2,428,829

 
3.1

 
5.2
%
Other Equity and Debt(2)
 
 
 
 
 
 
 
 
 
 
Net lease real estate equity
 
Fixed
 
335,375

 
334,739

 
5.8

 
4.2
%
Other real estate equity
 
Fixed
 
87,286

 
25,656

 
4.3

 
3.1
%
Other real estate equity
 
Floating
 
1,421,897

 
765,251

 
4.1

 
4.6
%
Real estate debt
 
Floating
 
36,747

 
23,779

 
1.3

 
5.2
%
GP Co-investments
 
Floating
 
656,571

 
421,611

 
3.1

 
4.3
%
Total investment-level debt(2)
 
 
 
$
9,479,565

 
$
6,731,560

 
3.6

 
5.0
%
 
 
 
 
 
 
 
 
 
 
 
Fixed / Floating Summary
Fixed
 
 
 
$
3,676,195

 
$
2,283,448

 
 
 
 
Floating
 
 
 
5,803,370

 
4,448,112

 
 
 
 
Total investment-level debt(2)
 
 
 
$
9,479,565

 
$
6,731,560

 
 
 
 










Notes:
(1)
Based on 1-month LIBOR of 2.09% and 3-month LIBOR of 2.34%.
(2) Includes $196 million consolidated and CLNY OP share principal balance of debt related to assets held for sale.


Colony Capital | Supplemental Financial Report
 
15

 




IIIc. Capitalization - Revolving Credit Facility Overview
 

($ in thousands, except as noted; as of June 30, 2018)
 
 
Revolving credit facility
 
 
Maximum principal amount
 
$
1,000,000

Amount outstanding
 

Initial maturity
 
January 11, 2021

Fully-extended maturity
 
January 10, 2022

Interest rate
 
LIBOR + 2.25%

 
 
 
Financial covenants as defined in the Credit Agreement:
 
Covenant level
Consolidated Tangible Net Worth
 
Minimum $4,550 million
Consolidated Fixed Charge Coverage Ratio
 
Minimum 1.50 to 1.00
Interest Coverage Ratio(1)
 
Minimum 3.00 to 1.00
Consolidated Leverage Ratio
 
Maximum 0.65 to 1.00
 
 
 
Company status: As of June 30, 2018, CLNY is meeting all required covenant threshold levels























Notes:
(1)
Interest Coverage Ratio represents the ratio of the sum of (1) earnings from borrowing base assets and (2) certain investment management earnings divided by the greater of (a) actual interest expense on the revolving credit facility and (b) the average balance of the facility multiplied by 7.0% for the applicable quarter.

Colony Capital | Supplemental Financial Report
 
16

 




IIId. Capitalization - Corporate Securities Overview
 

($ in thousands, except per share data; as of June 30, 2018, unless otherwise noted)
Convertible/exchangeable debt
Description
 
Outstanding principal
 
Final due date
 
Interest rate
 
Conversion price (per share of common stock)
 
Conversion ratio
 
Conversion shares
 
Redemption date
5.0% Convertible senior notes
 
$
200,000

 
April 15, 2023
 
5.00% fixed
 
$
15.76

 
63.4700

 
12,694

 
On or after April 22, 2020(1)
3.875% Convertible senior notes
 
402,500

 
January 15, 2021
 
3.875% fixed
 
16.57

 
60.3431

 
24,288

 
On or after January 22, 2019(1)
5.375% Exchangeable senior notes
 
13,605

 
June 15, 2033
 
5.375% fixed
 
12.04

 
83.0837

 
1,130

 
On or after June 15, 2020(1)
Total convertible debt
 
$
616,105

 
 
 
 
 
 
 
 
 
 
 
 
TruPS
 
 
 
 
 
 
Description
 
Outstanding
principal
 
Final due date
 
Interest rate
Trust I
 
$
41,240

 
March 30, 2035
 
3M L + 3.25%
Trust II
 
25,780

 
June 30, 2035
 
3M L + 3.25%
Trust III
 
41,238

 
January 30, 2036
 
3M L + 2.83%
Trust IV
 
50,100

 
June 30, 2036
 
3M L + 2.80%
Trust V
 
30,100

 
September 30, 2036
 
3M L + 2.70%
Trust VI
 
25,100

 
December 30, 2036
 
3M L + 2.90%
Trust VII
 
31,459

 
April 30, 2037
 
3M L + 2.50%
Trust VIII
 
35,100

 
July 30, 2037
 
3M L + 2.70%
Total TruPS
 
$
280,117

 
 
 
 
Perpetual preferred stock
 
 
 
 
 
 
Description
 
Liquidation
preference
 
Shares
outstanding
 
Callable period
Series B 8.25% cumulative redeemable perpetual preferred stock
 
$
152,855

 
6,114

 
Callable
Series E 8.75% cumulative redeemable perpetual preferred stock
 
250,000

 
10,000

 
On or after May 15, 2019
Series G 7.5% cumulative redeemable perpetual preferred stock
 
86,250

 
3,450

 
On or after June 19, 2019
Series H 7.125% cumulative redeemable perpetual preferred stock
 
287,500

 
11,500

 
On or after April 13, 2020
Series I 7.15% cumulative redeemable perpetual preferred stock
 
345,000

 
13,800

 
On or after June 5, 2022
Series J 7.125% cumulative redeemable perpetual preferred stock
 
315,000

 
12,600

 
On or after September 22, 2022
Total preferred stock(2)
 
$
1,436,605

 
57,464

 
 



Notes:
(1)
Callable at principal amount only if CLNY common stock has traded at least 130% of the conversion price for 20 of 30 consecutive trading days.
(2) Excludes $200 million redeemed in the third quarter 2018.

Colony Capital | Supplemental Financial Report
 
17

 




IIIe. Capitalization - Debt Maturity and Amortization Schedules
 

($ in thousands; as of June 30, 2018)
Consolidated debt maturity and amortization schedule
Payments due by period(1)
 
Fixed / Floating
2018
 
2019
 
2020
 
2021
 
2022 and after
 
Total
$1,000,000 Revolving credit facility
Floating
$

 
$

 
$

 
$

 
$

 
$

Convertible/exchangeable senior notes
Fixed

 

 

 
402,500

 
213,605

 
616,105

Corporate aircraft promissory note
Fixed
1,529

 
2,124

 
2,233

 
2,350

 
29,977

 
38,213

TruPS
Floating

 

 

 

 
280,117

 
280,117

Investment-level debt:
 
 
 
 
 
 
 
 
 
 
 
 
Healthcare
Fixed
111

 
1,750,231

 
7,052

 
8,338

 
403,182

 
2,168,914

Healthcare
Floating
14,788

 
624,221

 
52,251

 
397,463

 

 
1,088,723

Industrial
Fixed
407

 
839

 
875

 
2,350

 
1,069,359

 
1,073,830

Hospitality
Fixed

 

 

 
10,790

 

 
10,790

Hospitality
Floating

 
512,000

(2) 
247,750

 
209,682

 
1,630,000

 
2,599,432

Other Equity and Debt
Fixed
48,660

 
14,930

 
15,058

 
26,957

 
317,056

 
422,661

Other Equity and Debt
Floating
174,310

 
253,074

 
54,196

 
437,694

 
1,195,941

 
2,115,215

Total debt(3)
 
$
239,805

 
$
3,157,419

 
$
379,415

 
$
1,498,124

 
$
5,139,237

 
$
10,414,000

 
Pro rata debt maturity and amortization schedule
Payments due by period(1)
 
Fixed / Floating
2018
 
2019
 
2020
 
2021
 
2022 and after
 
Total
$1,000,000 Revolving credit facility
Floating
$

 
$

 
$

 
$

 
$

 
$

Convertible/exchangeable senior notes
Fixed

 

 

 
402,500

 
213,605

 
616,105

Corporate aircraft promissory note
Fixed
1,529

 
2,124

 
2,233

 
2,350

 
29,977

 
38,213

TruPS
Floating

 

 

 

 
280,117

 
280,117

Investment-level debt:
 
 
 
 
 
 
 
 
 
 
 
 
Healthcare
Fixed
77

 
1,218,861

 
4,950

 
5,852

 
283,005

 
1,512,745

Healthcare
Floating
10,670

 
440,145

 
42,314

 
315,513

 

 
808,642

Industrial
Fixed
152

 
313

 
326

 
875

 
398,122

 
399,788

Hospitality
Fixed

 

 

 
10,520

 

 
10,520

Hospitality
Floating

 
512,000

(2) 
247,750

 
204,440

 
1,464,639

 
2,428,829

Other Equity and Debt
Fixed
39,937

 
5,325

 
5,408

 
9,433

 
300,292

 
360,395

Other Equity and Debt
Floating
41,813

 
119,482

 
27,744

 
399,421

 
622,181

 
1,210,641

Total debt(3)
 
$
94,178

 
$
2,298,250

 
$
330,725

 
$
1,350,904

 
$
3,591,938

 
$
7,665,995

Notes:
(1)
Based on initial maturity dates or extended maturity dates to the extent criteria are met and the extension option is at the borrower’s discretion.
(2) During the third quarter 2018, refinanced and extended the fully extended maturity date from 2019 to 2025.
(3) Includes $196 million consolidated and CLNY OP share principal balance of debt related to assets held for sale.


Colony Capital | Supplemental Financial Report
 
18

 




IVa. Healthcare Real Estate - Summary Metrics and Operating Results
 

($ in thousands; as of or for the three months ended June 30, 2018, unless otherwise noted)
 
Consolidated amount
 
CLNY OP share of consolidated amount(1)
Net operating income
 
 
Net operating income:
 
 
 
 
Senior Housing - Operating
 
$
16,770

 
$
11,890

Medical Office Buildings
 
13,718

 
9,726

Triple-Net Lease:
 
 
 
 
Senior Housing
 
14,483

 
10,268

Skilled Nursing Facilities
 
24,079

 
17,072

Hospitals
 
4,806

 
3,407

Total net operating income(2)
 
$
73,856

 
$
52,363

Portfolio overview
 
Total number of buildings
 
Capacity
 
% Occupied(3)
 
TTM Lease Coverage(4)
 
WA Remaining
 Lease Term
Senior Housing - Operating
 
109

 
6,436 units
 
86.8
%
 
 N/A
 
 N/A

Medical Office Buildings
 
108

 
3.8 million sq. ft.
 
82.6
%
 
 N/A
 
N/A

Triple-Net Lease:
 
 
 
 
 
 
 
 
 
 
Senior Housing
 
83

 
4,153 units
 
82.3
%
 
1.4x
 
11.5

Skilled Nursing Facilities
 
99

 
11,829 beds
 
82.2
%
 
1.2x
 
6.4

Hospitals
 
14

 
872 beds
 
59.6
%
 
3.3x
 
10.8

Total
 
413

 
 
 


 
 
 


Same store financial/operating results related to the segment
 
 
 
 
 
 
 
 
% Occupied(3)
 
TTM Lease Coverage(4)
 
NOI(5)
 
 
Q2 2018
 
Q1 2018
 
3/31/2018
 
12/31/2017
 
Q2 2018
 
Q1 2018
 
% Change
Senior Housing - Operating
 
86.8
%
 
86.4
%
 
N/A
 
N/A
 
$
17,420

 
$
17,472

 
(0.3
)%
Medical Office Buildings
 
82.6
%
 
83.2
%
 
N/A
 
N/A
 
13,718

 
13,320

 
3.0
 %
Triple-Net Lease:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Senior Housing
 
82.3
%
 
83.2
%
 
1.4x
 
1.4x
 
15,544

 
15,530

 
0.1
 %
Skilled Nursing Facilities
 
82.2
%
 
82.7
%
 
1.2x
 
1.2x
 
25,942

 
26,854

 
(3.4
)%
Hospitals
 
59.6
%
 
55.3
%
 
3.3x
 
3.5x
 
4,806

 
4,923

 
(2.4
)%
Total
 
 
 
 
 
 
 
 
 
$
77,430

 
$
78,099

 
(0.9
)%

Notes:
(1)
CLNY OP Share represents Consolidated NOI multiplied by CLNY OP's interest of 71% as of June 30, 2018.
(2)
NOI includes $1.4 million consolidated or $1.0 million CLNY OP share of interest earned related to $77 million consolidated or $54 million CLNY OP share carrying value of healthcare real estate development loans. This interest income is in the Interest Income line item on the Company’s Statement of Operations for the three months ended June 30, 2018. For a reconciliation of net income/(loss) attributable to common stockholders to NOI, please refer to the appendix to this presentation.
(3)
Occupancy % for Senior Housing - Operating represents average of the presented quarter, MOB’s is as of last day in the quarter and for Triple-Net Lease represents average of the prior quarter. Occupancy represents real estate property operator’s patient occupancy for all types except MOB.
(4)
Represents the ratio of the tenant's/operator's EBITDAR to cash rent payable to the Company's Healthcare Real Estate segment on a trailing twelve month basis. Refer to Important Notes Regarding Non-GAAP Financial Measures and Definitions pages in this presentation for additional information regarding the use of tenant/operator EBITDAR.
(5)
Same Store Consolidated NOI excludes $3.2 million of termination fee revenue in Q1 2018 and excludes $3.6 million of non-recurring bad debt expense in Q2 2018.

Colony Capital | Supplemental Financial Report
 
19

 




IVb. Healthcare Real Estate - Portfolio Overview
 

(As of or for the three months ended June 30, 2018, unless otherwise noted)
Triple-Net Lease Coverage(1)
 
 
 
% of Triple-Net Lease TTM NOI as of March 31, 2018
 
 
March 31, 2018 TTM Lease Coverage
 
# of Leases
 
Senior Housing
 
Skilled Nursing Facilities & Hospitals
 
% Total NOI
 
WA Remaining Lease Term
Less than 0.99x
 
6

 
7
%
 
17
%
 
24
%
 
                  7 yrs

1.00x - 1.09x
 
2

 
%
 
14
%
 
14
%
 
                  6 yrs

1.10x - 1.19x
 

 
%
 
%
 
%
 

1.20x - 1.29x
 
1

 
4
%
 
%
 
4
%
 
                 10 yrs

1.30x - 1.39x
 
2

 
%
 
17
%
 
17
%
 
                  8 yrs

1.40x - 1.49x
 
1

 
%
 
2
%
 
2
%
 
                  8 yrs

1.50x and greater
 
5

 
19
%
 
20
%
 
39
%
 
                9 yrs

Total / W.A.
 
17

 
30
%
 
70
%
 
100
%
 
           8 yrs

Revenue Mix(2)
 
March 31, 2018 TTM
 
 
Private Pay
 
Medicare
 
Medicaid
Senior Housing - Operating
 
87
%
 
3
%
 
10
%
Medical Office Buildings
 
100
%
 
%
 
%
Triple-Net Lease:
 
 
 
 
 
 
Senior Housing
 
65
%
 
%
 
35
%
Skilled Nursing Facilities
 
26
%
 
20
%
 
54
%
Hospitals
 
11
%
 
40
%
 
49
%
W.A.
 
60
%
 
10
%
 
30
%









Notes:
(1)
Represents the ratio of the tenant's/operator's EBITDAR to cash rent payable to the Company's Healthcare Real Estate segment on a trailing twelve month basis. Refer to Important Notes Regarding Non-GAAP Financial Measures and Definitions pages in this presentation for additional information regarding the use of tenant/operator EBITDAR. Represents leases with EBITDAR coverage in each listed range. Excludes interest income associated with triple-net lease senior housing and hospital types. Caring Homes (U.K.) lease (EBITDAR) coverage includes additional collateral provided by the operator.
(2)
Revenue mix represents percentage of revenues derived from private, Medicare and Medicaid payor sources. The payor source percentages for the hospital category excludes two operating partners, whom do not track or report payor source data and totals approximately one-third of NOI in the hospital category. Overall percentages are weighted by NOI exposure in each category.

Colony Capital | Supplemental Financial Report
 
20

 




IVb. Healthcare Real Estate - Portfolio Overview (cont’d)
 

($ in thousands; as of or for the three months ended June 30, 2018, unless otherwise noted)
Top 10 Geographic Locations by NOI
 
 
Number of
buildings
 
NOI
United Kingdom
 
44

 
$
10,102

Indiana
 
55

 
7,323

Illinois
 
35

 
6,338

Florida
 
27

 
5,846

Oregon
 
31

 
4,932

Pennsylvania
 
11

 
4,807

California
 
15

 
4,552

Georgia
 
22

 
4,515

Texas
 
31

 
4,494

Ohio
 
35

 
4,340

Total
 
306

 
$
57,249

Top 10 Operators/Tenants by NOI
 
 
Property Type/Primary Segment
 
Number of
buildings
 
NOI
 
% Occupied
 
TTM Lease Coverage
 
WA Remaining Lease Term
Senior Lifestyle
 
Sr. Housing / RIDEA
 
82

 
$
13,823

 
87.0
%
 
N/A
 
N/A
Caring Homes (U.K.)(1)
 
Sr. Housing / NNN
 
44

 
10,102

 
86.7
%
 
               1.5x
 
15 yrs
Sentosa
 
SNF / NNN
 
11

 
4,807

 
87.6
%
 
1.3x
 
10 yrs
Wellington Healthcare
 
SNF / NNN
 
11

 
4,429

 
89.1
%
 
                1.1x
 
9 yrs
Miller
 
SNF / NNN
 
28

 
3,848

 
72.0
%
 
              2.0x
 
N/A
Frontier
 
Sr. Housing / RIDEA / NNN
 
20

 
3,822

 
82.9
%
 
N/A
 
N/A
Opis
 
SNF / NNN
 
11

 
2,806

 
89.2
%
 
1.3x
 
6 yrs
Grace
 
SNF / NNN
 
9

 
2,604

 
80.5
%
 
0.9x
 
3 yrs
Avanti Hospital Systems
 
Hospital
 
5

 
2,293

 
54.3
%
 
4.9x
 
9 yrs
Consulate
 
SNF / NNN
 
10

 
2,018

 
80.1
%
 
              0.4x
 
10 yrs
Total
 
 
 
231

 
$
50,552

 
 
 
 
 
 








Notes:
(1)
Caring Homes (U.K.) lease (EBITDAR) coverage includes additional collateral provided by the operator.

Colony Capital | Supplemental Financial Report
 
21

 




Va. Industrial Real Estate - Summary Metrics and Operating Results
 





($ in thousands; as of or for the three months ended June 30, 2018, unless otherwise noted)
 
Consolidated amount(1)
 
CLNY OP share of consolidated amount(1)
Net operating income
 
 
Net operating income
 
$
49,078

 
$
18,257

Portfolio overview
Total number of buildings
 
392

Rentable square feet (thousands)
 
47,497

% leased at end of period
 
92.9
%
Average remaining lease term
 
3.8

Same store financial/operating results related to the segment
 
Q2 2018
 
Q1 2018
 
% Change
Same store number of buildings
 
304

 
304

 

% leased at end of period
 
93.9
%
 
95.1
%
 
(1.3
)%
NOI
 
$
35,490

 
$
35,127

 
1.0
 %
Recent acquisitions & dispositions
 
Acquisition / Disposition
date
 
Number of
buildings
 
Rentable
square feet (thousands)
 
% leased
 
Purchase price / Sales price
Q2 2018 acquisitions:
 
 
 
 
 
 
 
 
 
 
San Francisco industrial portfolio
 
4/13/2018
 
2

 
587

 
100.0
%
 
$
100,500

Las Vegas industrial portfolio
 
4/24/2018
 
2

 
363

 
45.0
%
 
37,400

Northern NJ industrial portfolio
 
6/21/2018
 
10

 
640

 
91.3
%
 
95,997

San Antonio industrial portfolio
 
6/28/2018
 
1

 
359

 
%
 
23,400

Land for development
 
Various
 
N/A

 
N/A

 
N/A

 
589

Total / W.A.
 
 
 
15

 
1,949

 
68.5
%
 
$
257,886

 
 
 
 
 
 
 
 
 
 
 
Q2 2018 dispositions:
 
 
 
 
 
 
 
 
 
 
Southern NJ industrial property
 
5/29/2018
 
1

 
45

 
%
 
$
2,500

Total / W.A.
 
 
 
1

 
45

 
%
 
$
2,500

 
 
 
 
 
 
 
 
 
 
 
Q3 2018 acquisitions:
 
 
 
 
 
 
 
 
 
 
Baltimore industrial portfolio
 
7/2/2018
 
1

 
90

 
%
 
$
7,900

Baltimore industrial portfolio
 
7/12/2018
 
2

 
220

 
100.0
%
 
$
19,550

Las Vegas industrial portfolio
 
7/30/2018
 
2

 
205

 
100.0
%
 
$
15,995

Total / W.A.

 
 
 
5

 
515

 
81.8
%
 
$
43,445


Notes:
(1)
CLNY OP Share represents Consolidated NOI multiplied by CLNY OP's interest of 37% as of June 30, 2018. For a reconciliation of net income/(loss) attributable to common stockholders to NOI, please refer to the appendix to this presentation.

Colony Capital | Supplemental Financial Report
 
22

 




Vb. Industrial Real Estate - Portfolio Overview
 

($ in thousands; as of or for the three months ended June 30, 2018, unless otherwise noted)
 
 
 
 
Top 10 Geographic Locations by NOI
 
Number of buildings
 
Rentable square feet (thousands)
 
NOI
 
% leased at end of period
Dallas
 
68

 
7,426

 
$
7,401

 
93.9
%
Atlanta
 
62

 
6,862

 
6,783

 
97.3
%
New Jersey, South / Philadelphia
 
33

 
3,718

 
3,803

 
93.4
%
Minneapolis
 
18

 
2,814

 
3,745

 
96.1
%
Orlando
 
17

 
2,851

 
3,526

 
97.9
%
Phoenix
 
28

 
3,230

 
3,293

 
98.4
%
Maryland-BWI
 
21

 
2,806

 
3,178

 
93.5
%
Chicago
 
26

 
2,786

 
2,601

 
83.7
%
Houston
 
23

 
2,092

 
2,386

 
87.9
%
Jacksonville
 
11

 
2,011

 
2,013

 
99.9
%
    Total / W.A.
 
307

 
36,596

 
$
38,729

 
94.5
%
Top 10 Tenant Base by Industry
 
 
 
 
Industry
 
Total leased square feet (thousands)
 
% of total
Warehousing & Transportation
 
17,444

 
39.6
%
Manufacturing
 
7,699

 
17.5
%
Wholesale Trade
 
4,345

 
9.9
%
Professional, Scientific, and Technical Services
 
4,242

 
9.6
%
Media & Information
 
2,911

 
6.6
%
Health & Science
 
2,923

 
6.6
%
Construction & Contractors
 
2,247

 
5.1
%
Retail Trade
 
1,213

 
2.8
%
Entertainment & Recreation
 
935

 
2.1
%
Public Administration & Government
 
113

 
0.2
%
    Total
 
44,072

 
100.0
%



Colony Capital | Supplemental Financial Report
 
23

 




VIa. Hospitality Real Estate - Summary Metrics and Operating Results
 

($ in thousands; as of or for the three months ended June 30, 2018, unless otherwise noted)
 
 
 
CLNY OP share of consolidated amount(1)
EBITDA
 
Consolidated amount
 
EBITDA:
 
 
 
 
    Select Service
 
$
48,103

 
$
45,361

    Extended Stay
 
33,549

 
31,637

    Full Service
 
4,326

 
4,079

Total EBITDA(2)
 
$
85,978

 
$
81,077

Portfolio overview by type
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of hotels
 
Number of rooms
 
Avg. qtr. % occupancy
 
Avg. daily rate (ADR)
 
RevPAR
 
Q2 2018 EBITDA
 
EBITDA margin
Select service
 
97

 
13,193

 
77.7
%
 
$
127

 
$
99

 
$
48,103

 
37.0
%
Extended stay
 
66

 
7,936

 
82.9
%
 
136

 
113

 
33,549

 
40.2
%
Full service
 
4

 
962

 
77.3
%
 
166

 
128

 
4,326

 
27.7
%
    Total / W.A.
 
167

 
22,091

 
79.6
%
 
$
132

 
$
105

 
$
85,978

 
37.5
%

Same store financial/operating results related to the segment by brand
 
 
 
 
 
 
 
 
 
 
 
 
Avg. qtr. % occupancy
 
Avg. daily rate (ADR)
 
RevPAR
 
EBITDA
Brand
 
Q2 2018
 
Q2 2017
 
Q2 2018
 
Q2 2017
 
Q2 2018
 
Q2 2017
 
Q2 2018
 
Q2 2017
 
% Change
Marriott
 
78.3
%
 
77.0
%
 
$
131

 
$
129

 
$
102

 
$
99

 
$
66,313

 
$
62,834

 
5.5
 %
Hilton
 
83.9
%
 
82.0
%
 
135

 
131

 
113

 
107

 
14,763

 
13,862

 
6.5
 %
Other
 
86.3
%
 
84.2
%
 
138

 
139

 
119

 
117

 
4,902

 
4,995

 
(1.9
)%
Total / W.A.
 
79.6
%
 
78.2
%
 
$
132

 
$
130

 
$
105

 
$
102

 
$
85,978

 
$
81,691

 
5.2
 %







Notes:
(1)
CLNY OP Share represents Consolidated EBITDA multiplied by CLNY OP's interest of 94% as of June 30, 2018.
(2)
Q2 2018 EBITDA excludes a FF&E reserve contribution amount of $10.0 million consolidated or $9.4 million CLNY OP share. For a reconciliation of net income/(loss) attributable to common stockholders to EBITDA please refer to the appendix to this presentation.

Colony Capital | Supplemental Financial Report
 
24

 




VIb. Hospitality Real Estate - Portfolio Overview
 

($ in thousands; as of June 30, 2018, unless otherwise noted)
Top 10 Geographic Locations by EBITDA
 
Number of
hotels
 
Number of
rooms
 
Number of
rooms-select service
 
Number of
rooms-extended stay
 
Number of
rooms-full service
 
EBITDA
California
 
18

 
2,254

 
1,243

 
1,011

 

 
$
12,736

Texas
 
28

 
3,230

 
1,952

 
1,278

 

 
9,260

Florida
 
12

 
2,060

 
1,186

 
291

 
583

 
7,213

New Jersey
 
12

 
1,884

 
718

 
942

 
224

 
6,917

Virginia
 
11

 
1,473

 
1,210

 
263

 

 
5,530

New York
 
8

 
1,010

 
710

 
300

 

 
4,188

Washington
 
5

 
664

 
160

 
504

 

 
3,993

North Carolina
 
7

 
981

 
831

 
150

 

 
3,820

Georgia
 
7

 
974

 
694

 
280

 

 
3,444

Michigan
 
6

 
809

 
601

 
208

 

 
3,362

Total / W.A.
 
114

 
15,339

 
9,305

 
5,227

 
807

 
$
60,463



Colony Capital | Supplemental Financial Report
 
25

 




VIIa. CLNC
 


($ in thousands, except as noted and per share data; as of June 30, 2018, unless otherwise noted)
 
Consolidated amount
 
CLNY OP share of consolidated amount
Colony Credit Real Estate, Inc. (NYSE: CLNC)
 
 
 
 
CLNY OP interest in CLNC as of August 6, 2018
 
36.6
%
 
36.6
%
CLNC shares beneficially owned by OP and common stockholders
 
48.0 million

 
48.0 million

CLNC share price as of August 6, 2018
 
$
21.08

 
$
21.08

Total market value of CLNC shares
 
$
1,011,376

 
$
1,011,376

Net carrying value - CLNC
 
$
1,146,355

 
$
1,146,355

 
 
 
 
 









































Colony Capital | Supplemental Financial Report
 
26

 




VIIIa. Other Equity and Debt - Strategic Investments
 

($ in thousands, except as noted and per share data; as of June 30, 2018, unless otherwise noted)
 
Consolidated amount
 
CLNY OP share of consolidated amount
NorthStar Realty Europe Corp. (NYSE: NRE)
 
 
 
 
CLNY OP interest in NRE as of August 6, 2018
 
11.2
%
 
11.2
%
NRE shares beneficially owned by OP and common stockholders
 
5.6 million

 
5.6 million

NRE share price as of August 6, 2018
 
$
13.52

 
$
13.52

Total market value of NRE shares
 
$
76,206

 
$
76,206

Carrying value - NRE
 
75,044

 
75,044

 
 
 
 
 
CLNY's GP Co-investments in CDCF IV Investments - CLNY's Most Recent Flagship Institutional Credit Fund
 
 
 
 
Assets - carrying value(1)
 
$
1,112,419

 
$
199,057

Debt - UPB
 
293,397

 
58,437

Net carrying value
 
$
819,022

 
$
140,620

 
 
 
 
 
NBV by Geography:
 
 
 
 
U.S.
 
27.6
%
 
16.0
%
Europe
 
72.4
%
 
84.0
%
Total
 
100.0
%
 
100.0
%
 
 
 
 
 
Other GP Co-investments (2)
 
 
 
 
Assets - carrying value(1)
 
$
688,186

 
$
644,296

Debt - UPB
 
363,174

 
363,174

Net carrying value
 
$
325,012

 
$
281,122











Notes:
(1)
$1.1 billion consolidated and $573 million CLNY OP share are classified as Loans Receivable on the Company's balance sheet.
(2)
Other GP co-investments represents: i) seed investments in certain registered investment companies sponsored by the Company, ii) investments in the general partnership of third party real estate operators primarily to seed investment commitments with their limited partners for which the Company will receive its share of earnings and incentive fees, or iii) general partnership capital in a fund or investment.

Colony Capital | Supplemental Financial Report
 
27

 




VIIIb. Other Equity and Debt - Net Lease and Other Real Estate Equity
 

($ in thousands; as of June 30, 2018, unless otherwise noted)
Net Lease Real Estate Equity
 
Number of buildings
 
Rentable square feet
(thousands)
 
Consolidated amount
 
CLNY OP share of consolidated amount
 
% leased at end of period
 
Weighted average remaining lease term
 
 
 
 
NOI
 
NOI
 
 
U.S. office
 
5

 
878

 
$
2,415

 
$
2,283

 
80.6
%
 
5.1

Europe office
 
29

 
1,478

 
5,514

 
5,514

 
100.0
%
 
11.6

Total / W.A.
 
34

 
2,356

 
$
7,929

 
$
7,797

 
92.8
%
 
9.2

Other Real Estate Equity
 
Number of buildings
 
Rentable square feet
(thousands)
 
Consolidated amount
 
CLNY OP share of consolidated amount
 
% leased at end of period
 
Weighted average remaining lease term
 
 
 
 
Undepreciated
 carrying value
 
Undepreciated
carrying value
 
 
U.S.:
 
 
 
 
 
 
 
 
 
 
 
 
Office
 
14

 
1,482

 
$
272,779

 
$
236,558

 
66.6
%
 
5.8

Hotel(1)
 
100

 
N/A

 
1,234,872

 
680,736

 
75.0
%
 
N/A

 
 
 
 
 
 
 
 
 
 
 
 
 
Europe:
 
 
 
 
 
 
 
 
 
 
 
 
Industrial
 
37

 
2,753

 
163,942

 
73,774

 
100.0
%
 
6.0

Office
 
27

 
920

 
83,551

 
41,776

 
80.2
%
 
11.7

Mixed / Retail
 
151

 
4,390

 
698,032

 
238,719

 
63.3
%
 
4.2

Total / W.A.
 
329

 
9,545

 
$
2,453,176

 
$
1,271,563

 
76.0
%
 
5.7

 
 
 
 
 
 
 
 
 
 
 
 
 
Unconsolidated joint ventures (Other RE Equity)
 
 
 
 
 
 
 
 
Preferred equity:
 
 
 
 
 
 
 
 
 
 
 
 
Multifamily
 
 
 
 
 
$
341,676

 
$
341,676

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity & Other:
 
 
 
 
 
 
 
 
 
 
 
 
Albertsons
 
 
 
 
 
89,129

 
44,564

 
 
 
 
Residential Land
 
 
 
 
 
66,830

 
34,734

 
 
 
 
Other
 
 
 
 
 
28,742

 
28,742

 
 
 
 
Corporate CLO Equity
 
 
 
 
 
17,965

 
17,965

 
 
 
 
Multifamily
 
 
 
 
 
10,372

 
9,335

 
 
 
 
Total
 


 


 
$
554,714

 
$
477,016

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




Notes:
(1)
Includes $150 million consolidated or $83 million CLNY OP share of restricted cash.

Colony Capital | Supplemental Financial Report
 
28

 




VIIIc. Other Equity and Debt - Real Estate Debt
 

($ in thousands, except as noted; as of June 30, 2018, unless otherwise noted)
 
 
 
 
Portfolio Overview(1)
 
 
 
 
 
 
Consolidated amount
 
CLNY OP share of
consolidated amount
Non-PCI loans(2)
 
 
 
 
Carrying value - consolidated
 
$
492,573

 
$
352,537

Non-recourse investment-level financing (UPB)
 
22,523

 
16,456

Carrying value - equity method investments
 
27,037

 
19,527

 
 
 
 
.
PCI loans(2)
 
 
 
 
Carrying value - consolidated
 
121,918

 
55,019

Non-recourse investment-level financing (UPB)
 
14,224

 
7,323

Carrying value - equity method investments
 
1,368

 
1,368

 
 
 
 
 
Other
 
 
 
 
Carrying value - real estate assets (REO)
 
25,721

 
14,689

 
 
 
 
 
Total Portfolio
 
 
 
 
Carrying value - consolidated
 
614,491

 
407,556

Carrying value - equity method investments
 
28,405

 
20,895

Carrying value - real estate assets (REO)
 
25,721

 
14,689

Non-recourse investment-level financing (UPB)
 
36,747

 
23,779

















Notes:
(1)
Excludes $77 million consolidated or $54 million CLNY OP share carrying value of healthcare real estate development loans.
(2)
Strategic Non-PCI and PCI loans that are classified as Loans Receivable on the Company's balance sheet are categorized within GP co-investments in this supplemental financial presentation.

Colony Capital | Supplemental Financial Report
 
29

 




VIIIc. Other Equity and Debt - Real Estate Debt (cont’d)
 

($ in thousands; as of or for the three months ended June 30, 2018, unless otherwise noted)
Non-strategic real estate debt by loan type(1)
 
 
 
 
 
 
 
 
 
 
Consolidated amount
 
CLNY OP share of consolidated amount
 
 
Net carrying
amount
 
Net carrying
amount
 
Weighted average
yield
 
Weighted average maturity in years
Non-PCI loans(2)
 
 
 
 
 
 
 
 
Fixed rate
 
 
 
 
 
 
 
 
First mortgage loans
 
$
63,979

 
$
46,757

 
8.6
%
 
9.2

Second mortgage loans / B-notes
 
211,182

 
116,392

 
7.8
%
 
2.3

Mezzanine loans
 
122,937

 
93,634

 
2.9
%
 
1.6

Corporate
 
28,290

 
28,290

 
8.1
%
 
8.5

Total fixed rate non-PCI loans
 
426,388

 
285,073

 
6.3
%
 
3.8

 
 
 
 
 
 
 
 
 
Variable rate
 
 
 
 
 
 
 
 
First mortgage loans
 
69,901

 
69,901

 
8.9
%
 
2.0

Total variable rate non-PCI loans
 
69,901

 
69,901

 
8.9
%
 
2.0

 
 
 
 
 
 
 
 
 
Total non-PCI loans
 
496,289

 
354,974

 
 
 
 
Allowance for loan losses
 
(3,716
)
 
(2,437
)
 
 
 
 
Total non-PCI loans, net of allowance for loan losses

 
492,573

 
352,537

 
 
 
 
 
 
 
 
 
 
 
 
 
PCI loans(2)
 
 
 
 
 
 
 
 
First mortgage loans
 
167,890

 
62,964

 
 
 
 
Mezzanine loans
 
3,671

 
3,671

 
 
 
 
Total PCI loans
 
171,561

 
66,635

 
 
 
 
Allowance for loan losses
 
(49,643
)
 
(11,616
)
 
 
 
 
Total PCI loans, net of allowance for loan losses
 
121,918

 
55,019

 
 
 
 
 
 
 
 
 
 
 
 
 
Total loans receivable, net of allowance for loan losses
 
$
614,491

 
$
407,556

 
 
 
 







Notes:
(1)
Excludes $77 million consolidated or $54 million CLNY OP share carrying value of healthcare real estate development loans.
(2)
Strategic Non-PCI and PCI loans that are classified as Loans Receivable on the Company's balance sheet are categorized within GP co-investments in this supplemental financial presentation.

Colony Capital | Supplemental Financial Report
 
30

 




VIIIc. Other Equity and Debt - Real Estate Debt (cont’d)
 

($ in thousands; as of or for the three months ended June 30, 2018, unless otherwise noted)
 
 
 
 
 
 
Non-strategic real estate debt by collateral type(1)
 
 
 
 
 
 
 
 
 
 
Consolidated amount
 
CLNY OP share of consolidated amount
 
 
Net carrying
amount
 
Net carrying
amount
 
Weighted average
yield
 
Weighted average maturity in years
Non-PCI Loans(2)
 
 
 
 
 
 
 
 
Retail
 
$
171,674

 
$
160,932

 
3.6
%
 
1.0

Office
 
134,128

 
67,064

 
13.5
%
 
3.6

Multifamily
 
68,465

 
51,243

 
8.6
%
 
9.9

Corporate
 
28,290

 
28,290

 
8.1
%
 
8.5

Hospitality
 
52,578

 
26,289

 
10.3
%
 
2.1

Land
 
37,439

 
18,719

 
%
 
0.9

Total non-PCI loans, net of allowance for loan losses
 
492,574

 
352,537

 
6.9
%
 
3.5

 
 
 
 
 
 
 
 
 
PCI Loans(2)
 
 
 
 
 
 
 
 
Retail
 
45,459

 
23,290

 
 
 
 
Multifamily
 
26,785

 
11,401

 
 
 
 
Industrial
 
16,931

 
8,280

 
 
 
 
Office
 
5,061

 
4,114

 
 
 
 
Hospitality
 
14,088

 
2,818

 
 
 
 
Land
 
2,334

 
467

 
 
 
 
Residential
 
670

 
134

 
 
 
 
Other
 
10,590

 
4,515

 
 
 
 
Total PCI loans, net of allowance for loan losses
 
121,918

 
55,019

 
 
 
 
 
 
 
 
 
 
 
 
 
Total loans receivable, net of allowance for loan losses
 
$
614,492

 
$
407,556

 
 
 
 











Notes:
(1)
Excludes $77 million consolidated or $54 million CLNY OP share carrying value of healthcare real estate development loans.
(2)
Strategic Non-PCI and PCI loans that are classified as Loans Receivable on the Company's balance sheet are categorized within GP co-investments in this supplemental financial presentation.

Colony Capital | Supplemental Financial Report
 
31

 




VIIId. Other Equity and Debt - Real Estate PE Fund Interests
 

($ in thousands, except as noted; as of or for the three months ended June 30, 2018, unless otherwise noted)
 
 
Operating Results
 
 
Q2 2018 income(1)
 
$

Return of capital
 
23,066

Total distributions
 
23,066

Contributions
 
952

Net
 
$
22,114

 
 
 
Carrying value
 
$
142,744

Investment by Types(2)
 
 
Investment by Geography(2)
Type
 
%
 
 
Location
 
%
Land
 
24
%
 
 
Northeast
 
25
%
Multifamily
 
14
%
 
 
West
 
20
%
Office
 
14
%
 
 
Cash
 
14
%
Cash
 
14
%
 
 
Midwest
 
11
%
Other
 
11
%
 
 
Primarily Various U.S.
 
9
%
Retail
 
10
%
 
 
Southeast
 
6
%
Lodging
 
5
%
 
 
Asia
 
6
%
Residential/Condo
 
4
%
 
 
Mid-Atlantic
 
5
%
Debt
 
3
%
 
 
Europe
 
4
%
Industrial
 
1
%
 
 
 
 
 
Total
 
100
%
 
 
Total
 
100
%



















Notes:
(1)
As of June 30, 2018, the Company had contracts to sell the majority of its real estate private equity investments and concurrent with the sale the Company discontinued recognizing income for such investments.
(2)
Represents the underlying fund interests in PE Investments by investment type and geographic location based on NAV as of March 31, 2018.

Colony Capital | Supplemental Financial Report
 
32

 




VIIIe. Other Equity and Debt - CRE Securities
 

($ in thousands; as of June 30, 2018)
 
 
 
Portfolio Overview
 
 
Carrying Value
Deconsolidated CDO bonds
 
 
$
63,237

Deconsolidated CDO equity
 
 
14,770

CMBS
 
 
199

 
 
 
 
Core FFO
 
 
 
Q2 2018 aggregate Core FFO(1)
 
 
$
2,851






































Notes:
(1) Excludes Core FFO of a consolidated CDO and deconsolidated CDO bonds which the Company sold or were paid off during the second quarter 2018.

Colony Capital | Supplemental Financial Report
 
33

 




IXa. Investment Management - Summary Metrics
 

($ in thousands, except as noted; as of June 30, 2018)
 
Q2 2018 Fee Revenue - CLNY OP Share
Overview
 
 
 
Institutional funds(1)
 
$
17,171

Colony Credit Real Estate (NYSE:CLNC)
 
11,998

NorthStar Realty Europe (NYSE:NRE)
 
4,222

Retail companies
 
6,534

Non-wholly owned REIM platforms (earnings of investments in unconsolidated ventures)(2)
 
(809
)
Total Q2 2018 reported fee revenue and REIM platform earnings of investments in unconsolidated ventures
 
$
39,116

Operating Results
 
 
Revenues
 
 
Total fee revenue and REIM earnings of investments in unconsolidated ventures
 
$
39,116

Other income and commission income
 
9,618

Expenses
 
 
Investment, servicing and commission expenses
 
5,923

Depreciation and amortization
 
6,204

Impairment loss(3)
 
60,312

Compensation expense
 
15,299

Administrative expenses
 
1,959

Total expenses
 
89,697

Other gain (loss), net
 
(123
)
Earnings of investments in unconsolidated ventures(4)
 
(11,788
)
Income tax benefit
 
2,882

Net income attributable to common interests in OP and common stockholders
 
(49,992
)
Real estate depreciation and amortization
 
785

(Gain) loss from sales of depreciable real estate
 
(48
)
(Gains) and losses from sales of businesses within the Investment Management segment and impairment write-downs associated with the Investment Management segment
 
16,437

Equity-based compensation expense
 
1,815

Straight-line rent revenue and expense
 
(20
)
Amortization of deferred financing costs and debt premiums and discounts
 
55

Unrealized fair value gains or losses and foreign currency remeasurements
 
23

Amortization and impairment of investment management intangibles
 
66,550

Non-real estate depreciation and amortization
 
10

Tax (benefit) expense, net
 
(1,475
)
Core FFO
 
$
34,140


Notes:
(1)
Includes a $3 million fee related to fund raising in the second quarter 2018 for the investment in AccorInvest, the property arm of AccorHotels.
(2)
Earnings of investments in unconsolidated ventures includes a $4.2 million negative prior period adjustment related to the Company's investment in RXR Realty.
(3)
Includes a $60 million writeoff of an intangible asset related to the NorthStar trade name as a result of the name change of the Company from Colony NorthStar, Inc. to Colony Capital, Inc.
(4)
Includes $13 million of impairments to interests in non-wholly owned REIM platforms and $2 million of unrealized carried interest from the industrial platform.

Colony Capital | Supplemental Financial Report
 
34

 




IXb. Investment Management – Assets Under Management
 

($ in millions, except as noted; as of June 30, 2018, unless otherwise noted)
 
 
 
 
Segment
 
Products (FEEUM)
 
Description
 
AUM CLNY OP Share
 
FEEUM CLNY OP Share
 
Fee Rate
 
 
 
 
 
 
 
 
 
 
 
Institutional Funds
 
•    Credit ($2.7 billion)
•    Core plus / value-added ($0.3 billion)
•    Opportunistic ($0.5 billion)
•    Colony Industrial ($1.5 billion)
•    Other co-investment vehicles ($1.2 billion)
 
•    26 years of institutional investment management experience
•    Sponsorship of private equity funds and vehicles earning asset management fees and performance fees
•    More than 300 investor relationships
•    Colony Industrial Open-End Fund
 
$
9,955

 
$
6,172

 
.8
%
Public Companies
 
•    Colony Credit Real Estate, Inc. ($3.1 billion)
•    NorthStar Realty Europe Corp. ($1.1 billion)
 
•    CLNC: NYSE-listed credit focused REIT
•    NRE: NYSE-listed European equity REIT
•    Contracts with base management fees with potential for incentive fees
 
5,181

 
4,218

 
1.5
%
Retail Companies
 
•    NorthStar Healthcare ($1.6 billion)
•    NorthStar/RXR NY Metro Real Estate
•    NorthStar Real Estate Capital Income Funds(1)
 

•    Manage public non-traded vehicles earning asset management and performance fees
 
3,616

 
1,657

 
1.5
%
Non-Wholly Owned REIM Platforms
 
•    Digital Real Estate Infrastructure Co-sponsored Vehicle
•    RXR Realty
•    American Healthcare Investors
•    Steelwave
•    Hamburg Trust
 
•    CLNY recognizes at-share earnings from underlying non-wholly owned REIM platforms
•    50% investment in Digital Colony, the Company's digital real estate infrastructure vehicle established in partnership with Digital Bridge with an aggregate $3.0 billion of committed capital as of June 30, 2018
•    27% investment in RXR Realty, a real estate owner, developer and investment management company with $18 billion of AUM
•    43% investment in American Healthcare Investors, a healthcare investment management firm and sponsor of non-traded vehicles with $3 billion of AUM
 
9,392

 
5,033

 
N/A

Total
 
 
 
 
 
$
28,144

 
$
17,080

 





Notes:
(1)
NorthStar Real Estate Capital Income Funds represents a master/feeder structure and pools investor capital raised through three feeder funds.

Colony Capital | Supplemental Financial Report
 
35

 




 
 









APPENDICES

Colony Capital | Supplemental Financial Report
 
36

 




Xa. Appendices - Definitions
 

Assets Under Management (“AUM”)
Assets for which the Company and its affiliates provide investment management services, including assets for which the Company may or may not charge management fees and/or performance allocations. AUM is based on reported gross undepreciated carrying value of managed investments as reported by each underlying vehicle at June 30, 2018. AUM further includes a) uncalled capital commitments and b) includes the Company’s pro-rata share of each affiliate non wholly-owned real estate investment management platform’s assets as presented and calculated by the affiliate. Affiliates include the co-sponsored digital real estate infrastructure vehicle, RXR Realty LLC, SteelWave, LLC, American Healthcare Investors and Hamburg Trust. The Company's calculations of AUM may differ materially from the calculations of other asset managers, and as a result, this measure may not be comparable to similar measures presented by other asset managers.

CLNY OP
The operating partnership through which the Company conducts all of its activities and holds substantially all of its assets and liabilities. CLNY OP share excludes noncontrolling interests in investment entities.

Fee-Earning Equity Under Management (“FEEUM”)
Equity for which the Company and its affiliates provides investment management services and derives management fees and/or performance allocations. FEEUM generally represents a) the basis used to derive fees, which may be based on invested equity, stockholders’ equity, or fair value pursuant to the terms of each underlying investment management agreement and b) the Company’s pro-rata share of fee bearing equity of each affiliate as presented and calculated by the affiliate. Affiliates include the co-sponsored digital real estate infrastructure vehicle, RXR Realty LLC, SteelWave, LLC, American Healthcare Investors and Hamburg Trust. The Company's calculations of FEEUM may differ materially from the calculations of other asset managers, and as a result, this measure may not be comparable to similar measures presented by other asset managers.

Healthcare same store portfolio: defined as properties in operation throughout the full periods presented under the comparison and included 413 properties in the sequential quarter to quarter and year to year comparisons. Properties acquired, disposed or held for sale during these periods are excluded for the same store portfolio and same store results exclude termination fee revenue and certain non-recurring bad debt expense.

Industrial same store portfolio: consisted of 304 buildings. The same store portfolio is defined once a year at the beginning of the current calendar year and includes buildings that were owned, stabilized and held-for-use throughout the entirety of both the current and prior calendar years. Properties acquired, disposed or held-for-sale after the same store portfolio is determined are excluded. Stabilized properties are defined as properties owned for more than one year or are greater than 90% leased. Same store NOI excludes lease termination fee revenue.

Hospitality same store portfolio: defined as hotels in operation throughout the full periods presented under the comparison and included 167 hotels in the year to year comparison.

NOI: Net Operating Income. NOI for healthcare and industrial segments represents total property and related income less property operating expenses, adjusted for the effects of (i) straight-line rental income adjustments; (ii) amortization of acquired above- and below-market lease adjustments to rental income; and (iii) other items such as adjustments for the Company’s share of NOI of unconsolidated ventures.

EBITDA: Earnings before Interest, Income Taxes, Depreciation and Amortization. EBITDA for the hospitality segment represents net income from continuing operations of that segment excluding the impact of interest expense, income tax expense or benefit, and depreciation and amortization.










Colony Capital | Supplemental Financial Report
 
37

 




Xa. Appendices - Definitions
 



Earnings Before Interest, Tax, Depreciation, Amortization and Rent (“EBITDAR”)
Represents earnings before interest, taxes, depreciation, amortization and rent for facilities accruing to the tenant/operator of the property (not the Company) for the period presented. The Company uses EBITDAR in determining TTM Lease Coverage for triple-net lease properties in its Healthcare Real Estate segment. EBITDAR has limitations as an analytical tool. EBITDAR does not reflect historical cash expenditures or future cash requirements for facility capital expenditures or contractual commitments. In addition, EBITDAR does not represent a property's net income or cash flow from operations and should not be considered an alternative to those indicators. The Company utilizes EBITDAR as a supplemental measure of the ability of the Company's operators/tenants to generate sufficient liquidity to meet related obligations to the Company.

TTM Lease Coverage
Represents the ratio of EBITDAR to recognized cash rent for owned facilities on a trailing twelve month basis. TTM Lease Coverage is a supplemental measure of a tenant’s/operator’s ability to meet their cash rent obligations to the Company. However, its usefulness is limited by, among other things, the same factors that limit the usefulness of EBITDAR.

ADR: Average Daily Rate

RevPAR: Revenue per Available Room

UPB: Unpaid Principal Balance

PCI: Purchased Credit-Impaired

REIM: Real Estate Investment Management



Colony Capital | Supplemental Financial Report
 
38

 




Xb. Appendices - Reconciliation of Net Income (Loss) to NOI/EBITDA
 

($ in thousands; for the three months ended June 30, 2018)
 
 
 
 
 
 
 
 
NOI and EBITDA Determined as Follows
 
Healthcare
 
Industrial
 
Hospitality
 
Other Equity and Debt—Net Lease Properties
Total revenues
 
$
145,419

 
$
72,477

 
$
229,373

 
$
10,355

Straight-line rent revenue and amortization of above- and below-market lease intangibles
 
(1,580
)
 
(2,554
)
 
(6
)
 
(393
)
Interest income
 

 
(62
)
 

 

Other income
 

 

 
(68
)
 

Property operating expenses(1)
 
(69,983
)
 
(20,483
)
 
(143,321
)
 
(2,033
)
Compensation expense(1)
 

 
(300
)
 

 

NOI or EBITDA
 
$
73,856

 
$
49,078

 
$
85,978

 
$
7,929

 
 
 
 
 
 
 
 
 
Reconciliation of Net Income (Loss) from Continuing Operations to NOI/EBITDA
 
 
 
Healthcare
 
Industrial
 
Hospitality
 
 
Net income (loss) from continuing operations
 
$
(20,080
)
 
$
4,668

 
$
6,771

 
 
Adjustments:
 
 
 
 
 
 
 
 
Straight-line rent revenue and amortization of above- and below-market lease intangibles
 
(1,580
)
 
(2,554
)
 
(6
)
 
 
Interest income
 

 
(62
)
 

 
 
Interest expense
 
45,179

 
10,856

 
36,494

 
 
Transaction, investment and servicing costs
 
3,110

 
60

 
3,546

 
 
Depreciation and amortization
 
38,229

 
32,482

 
35,925

 
 
Impairment loss
 
1,982

 
174

 

 
 
Compensation and administrative expense
 
2,196

 
3,416

 
1,598

 
 
Other (gain) loss, net
 
4,465

 

 
162

 
 
Other income
 

 

 
(68
)
 
 
Income tax (benefit) expense
 
355

 
38

 
1,556

 
 
NOI or EBITDA
 
$
73,856

 
$
49,078

 
$
85,978

 
 






Notes:
(1)
For healthcare and hospitality, property operating expenses includes property management fees paid to third parties. For industrial, there are direct costs of managing the portfolio which are included in compensation expense.

Colony Capital | Supplemental Financial Report
 
39

 




Xb. Appendices - Reconciliation of Net Income (Loss) to NOI/EBITDA (cont’d)
 

($ in thousands; for the three months ended June 30, 2018)
 
 
Reconciliation of Net Income from Continuing Operations of Other Equity and Debt Segment to NOI of Net Lease Real Estate Equity
 
 
Other Equity and Debt
Net income from continuing operations
 
$
61,853

Adjustments:
 
 
Property operating income of other real estate equity
 
(135,500
)
Straight-line rent revenue and amortization of above- and below-market lease intangibles for net lease real estate equity
 
(375
)
Interest income
 
(42,586
)
Fee and other income
 
(2,509
)
Property operating expense of other real estate equity
 
84,836

Interest expense
 
46,476

Transaction, investment and servicing costs
 
13,362

Depreciation and amortization
 
23,521

Provision for loan loss
 
13,933

Impairment loss
 
7,366

Compensation and administrative expense
 
5,975

Gain on sale of real estate assets
 
(42,702
)
Other loss, net
 
(18,216
)
Earnings of investments in unconsolidated ventures
 
(7,767
)
Income tax expense
 
262

NOI of net lease real estate equity
 
$
7,929



Colony Capital | Supplemental Financial Report
 
40